Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!
of patients presenting with dyspnea to aid in Upper 24% 13% differentiation between chronic obstructive pulmonary disease Middle 21% 21% ( COPD ) and heart failure ( HF ). VRI is a noninvasive, bedside ...
, the COPD /VD/PVD group (Class 4) included the oldest patients (75 ± 11 years) and fewest Hispanic individuals among all patients hospitalized with AMI, while the diabetes/CKD/ HF group (Class 5) had the lowest ...
patients presenting with EOL conditions including cancer, chronic pulmonary disease ( COPD ), chronic kidney disease (CKD), heart failure ( HF ), cirrhosis, dementia, and progressive central nervous system (PCNS ...
50% of all patients with HF but only 30% of the control patients presented with atrial fibrillation. The predicted perioperative mortality according to the STS score varied between 4.1 (2.7–5.6 ...
that impairments in pulmonary vascular function may precede clinical HF and that a comprehensive pulmonary hemodynamic evaluation may identify pulmonary vascular phenotypes that differentially predict HF phenotypes ...
, emergency department, primary health care, and medications) using a Patient Encounter Costing methodology. Care of HF patients cost €58.6 M, (€9790/patient) representing 8.7% of RH’s total visit expenses ...
. Moreover, this disease is becoming the most costly cardiovascular illness(4), and current strategies of healthcare delivery in HF involve close cooperation between inpatient and outpatient care providers(5 ...
fibrillation; COPD : chronic obstructive pulmonary disease; CP: chest pain; ED: emergency department; EMS: emergency medical services; HF : heart failure; HTN: hypertension; km: kilometre; Non-ST ACS: non-ST ...
Abstract Aim Biomarkers can help to identity acute heart failure (AHF) as the cause of symptoms in patients presenting to the emergency department (ED). Older patients may prove a diagnostic ...
, the development of cell therapies for HF has been slow, plagued by multifarious problems, and punctuated by many setbacks; at present , the utility of cell therapy in HF remains to be determined. What the field ...
Access the full text.
Sign up today, get unlimited access with DeepDyve Pro!